Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2020 third-quarter earnings
Lede-What You Need to Know About Johnson & Johnson's 2020 Third-Quarter Earnings.jpg

What you need to know about Johnson & Johnson’s 2020 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon
2020 Q3 Earnings Infographic Johnson & Johnson

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Johnson & Johnson’s solid third-quarter performance reflects the strength of our business model, the quality and breadth of our portfolio and our relentless drive toward innovation,” says Joseph Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “We continue to be driven by our purpose to advance health for humanity as we work to accelerate the development of a safe, effective and affordable investigational COVID-19 vaccine candidate on a not-for-profit basis for pandemic use. The results in these extraordinary times were made possible by our colleagues around the world and their unwavering resilience and focus to deliver value to all of our stakeholders by providing healthcare solutions that benefit people in need globally.”

For more details about the company’s 2020 third-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.